Three new subtypes of multiple sclerosis (MS) have been identified by using artificial intelligence (AI). The new MS subtypes were...
A world-first trial is being launched in the UK into whether drugs already on the market can prevent multiple sclerosis (MS) from worsening and even reverse...
Approval has been given for use of a multiple sclerosis (MS) medication in Scotland, with a final decision on its introduction in England and Wales expected...
Vision in patients with multiple sclerosis (MS) could be improved through the use of medication, a new study has found. A mice study investigated the effect...
The effect of medication Tysabri on cognitive fatigue in people with multiple sclerosis (MS) is to be analysed in a new research study. The study will...
The types of nerve cells which are lost through developing Multiple Sclerosis (MS) have been identified for the first time, in a breakthrough which could yield...
Dedicated support for people living with Multiple Sclerosis (MS) is set to be increased through the addition of more specialist nurses and champions into the NHS...
Having felt so let down by the lack of support and guidance available to people with Multiple Sclerosis (MS), podcaster and campaigner Jessie Ace has now...
Michael was a high-flying company director when he was diagnosed with Multiple Sclerosis earlier this year. Only shortly afterwards, amidst the economic impact of the pandemic,...
The drug siponimod (Mayzent) has been approved by NICE for active secondary progressive MS in England and Wales. MS charity the MS Trust hailed the news...
